E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
10 / 08 / 2023

 


A study of cutaneous adverse drug reactions in a tertiary care hospital

Pauline Packiaseeli Stanislas.


Abstract
Background: Cutaneous reactions are the most common types of adverse drug reactions (ADRs). Drugs administered systemically are the important causes of cutaneous ADRs (CADRs). The physicians should be familiar with these CADRs so that it would help in early recognition and prompt withdrawal of drug. For this, a good knowledge about the pattern, frequency, and causative agents of dermatological adverse reactions in our hospital is needed.

Aims and Objectives: This study was done to reveal the pattern, frequency, and most common drugs causing dermatological ADRs in our institution. There is no such study done about the CADRs reported in our institution; so far, hence, this study was done.

Materials and Methods: In this study, the CADRs identified and reported by the dermatologist in the dermatology out-patient department as well in patients admitted in the dermatology ward were studied.

Results: The common CADRs were urticaria 42.3%, erythematous lesions 34.6%, Stevens–Johnson syndrome 15.3%, hyperpigmentation 7%, and maculopapular rash 7%. Among the different groups of drugs, antibiotics is at the top of the list with 31.3%, followed by antitubercular drugs 24.2%, antiretroviral drugs 21.3%, antiepileptic drugs 10%, and other miscellaneous drugs.

Conclusion: Early recognition of various CADRs is essential so that the offending drug is recognized and stopped immediately. This can also help in prevention of ADRs.

Key words: Cutaneous; Adverse Drug Reactions; Tertiary Care


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pauline Packiaseeli Stanislas
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Pauline Packiaseeli Stanislas. A study of cutaneous adverse drug reactions in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2024; 14(3): 409-412. doi:10.5455/njppp.2023.13.02097202331072023


Web Style

Pauline Packiaseeli Stanislas. A study of cutaneous adverse drug reactions in a tertiary care hospital. https://www.njppp.com/?mno=143955 [Access: March 14, 2024]. doi:10.5455/njppp.2023.13.02097202331072023


AMA (American Medical Association) Style

Pauline Packiaseeli Stanislas. A study of cutaneous adverse drug reactions in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2024; 14(3): 409-412. doi:10.5455/njppp.2023.13.02097202331072023



Vancouver/ICMJE Style

Pauline Packiaseeli Stanislas. A study of cutaneous adverse drug reactions in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2024), [cited March 14, 2024]; 14(3): 409-412. doi:10.5455/njppp.2023.13.02097202331072023



Harvard Style

Pauline Packiaseeli Stanislas (2024) A study of cutaneous adverse drug reactions in a tertiary care hospital. Natl J Physiol Pharm Pharmacol, 14 (3), 409-412. doi:10.5455/njppp.2023.13.02097202331072023



Turabian Style

Pauline Packiaseeli Stanislas. 2024. A study of cutaneous adverse drug reactions in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 14 (3), 409-412. doi:10.5455/njppp.2023.13.02097202331072023



Chicago Style

Pauline Packiaseeli Stanislas. "A study of cutaneous adverse drug reactions in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 409-412. doi:10.5455/njppp.2023.13.02097202331072023



MLA (The Modern Language Association) Style

Pauline Packiaseeli Stanislas. "A study of cutaneous adverse drug reactions in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 14.3 (2024), 409-412. Print. doi:10.5455/njppp.2023.13.02097202331072023



APA (American Psychological Association) Style

Pauline Packiaseeli Stanislas (2024) A study of cutaneous adverse drug reactions in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 14 (3), 409-412. doi:10.5455/njppp.2023.13.02097202331072023